4//SEC Filing
BOCHNOWSKI JAMES J 4
Accession 0001104659-23-062745
CIK 0001585608other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 5:04 PM ET
Size
7.9 KB
Accession
0001104659-23-062745
Insider Transaction Report
Form 4
BOCHNOWSKI JAMES J
Director
Transactions
- Exercise/Conversion
Common Stock
2023-05-17+1,280→ 2,263 total - Exercise/Conversion
Restricted stock units
2023-05-17−1,280→ 0 total→ Common Stock (1,280 underlying)
Footnotes (4)
- [F1]Granted pursuant to the issuer's 2014 Stock Incentive Plan.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F3]On January 23, 2023, the issuer effected a 75-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "January 2023 Reverse Stock Split). Upon effectiveness of the January 2023 Reverse Stock Split, every 75 shares of voting common stock was automatically converted into one share of voting common stock.
- [F4]The restricted stock units were previously reported as covering 96,015 shares, but were adjusted to reflect the January 2023 Reverse Stock Split. Such restricted stock units were granted on March 28, 2022 and vested in full on May 17, 2023. Vested shares will be delivered to the reporting person on the vesting date provided in the grant notice.
Documents
Issuer
Jaguar Health, Inc.
CIK 0001585608
Entity typeother
Related Parties
1- filerCIK 0001255743
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 5:04 PM ET
- Size
- 7.9 KB